Cargando…
Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma
Introduction: Urachal carcinoma (UrC) is a rare and aggressive disease. Systematic chemotherapy shows limited efficacy in patients with advanced disease, while targeted therapy and immunotherapy may provide a reasonable alternative for specific populations. The molecular pattern of colorectal cancer...
Autores principales: | Zheng, Yang, Peng, Heling, Hu, Xu, Ou, Yong, Wang, Dong, Wang, Han, Ren, Shangqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267743/ https://www.ncbi.nlm.nih.gov/pubmed/37324454 http://dx.doi.org/10.3389/fphar.2023.1199395 |
Ejemplares similares
-
Identifying an Immune-Related Gene ST8SIA1 as a Novel Target in Patients With Clear-Cell Renal Cell Carcinoma
por: Hu, Xu, et al.
Publicado: (2022) -
Treatment approaches for urachal cancer: Use of immunotherapy and targeted therapies
por: Benjamin, David J, et al.
Publicado: (2023) -
Urachal carcinoma
por: Abeygunasekera, Anuruddha M., et al.
Publicado: (2013) -
Immune Microenvironment Characteristics of Urachal Carcinoma and Its Implications for Prognosis and Immunotherapy
por: Zhang, Xinke, et al.
Publicado: (2022) -
Clinical comparison of patients with benign urachal masses versus urachal carcinomas
por: Bi, Xing, et al.
Publicado: (2017)